Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

New Findings on Drug Delivery with Nanoparticles

March 2, 2011 5:54 am | News | Comments

Researchers have shown that medicine designed at nanoscale offers unprecedented opportunities for targeted treatment of serious diseases such as cancer. However, research also shows that the body's immune system plays a part in the drug delivery process.

TOPICS:

Merck Receives CRL for Cladribine

March 2, 2011 5:50 am | News | Comments

Merck KGaA has received a complete response letter from the U.S. Food and Drug Administration on the new drug application for Cladribine Tablets, its investigational oral formulation of cladribine, a therapy for relapsing-remitting multiple sclerosis.

TOPICS:

FDA Approves Takeda's Edarbi

March 2, 2011 5:47 am | News | Comments

The U.S. Food and Drug Administration approved Edarbi tablets to treat high blood pressure in adults. Data from clinical studies showed Edarbi to be more effective in lowering 24-hour blood pressure compared with two other FDA-approved hypertension drugs.

TOPICS:
Advertisement

BMS R & D Head Joins Board

March 2, 2011 5:44 am | News | Comments

The drugmaker Bristol-Myers Squibb Co. said that Elliott Sigal he been elected to its board of directors. Sigal, 59, is the company's chief scientific officer and the president of its research and development unit.

TOPICS:

Indians Protest Pharmaceutical Trade Deal

March 2, 2011 5:42 am | News | Comments

More than 2,000 HIV-positive people from India and other Asian nations marched in New Delhi to demand the Indian government reject provisions on pharmaceuticals in the India-European Union free trade agreement.

TOPICS:

GTx-Ipsen End Toremifene Partnership

March 2, 2011 5:38 am | News | Comments

GTx Inc. said it is ending a development deal with drug maker Ipsen Ltd. over the bone drug toremifene. The drug is designed to reduce bone fractures in men who have prostate cancer and are being treated with androgen deprivation therapy.

TOPICS:

Mylan Estrogen Patch Triggers Lawsuits

March 2, 2011 5:36 am | News | Comments

Mylan Inc. said that it asked the Food and Drug Administration to approve a generic version of Noven Pharmaceuticals Inc.'s Vivelle-Dot estrogen patch, prompting patent lawsuits.

TOPICS:

Nektar Move Hits Bottom Line

March 2, 2011 5:33 am | News | Comments

Biotechnology company Nektar Therapeutics reported a larger fourth-quarter loss as it moved to a new research and development facility. The company said it lost $22.6 million, or 24 cents per share.

TOPICS:
Advertisement

Rigel Reports Narrower 4Q Loss

March 2, 2011 5:28 am | News | Comments

Rigel Pharmaceuticals Inc. said lower costs and a tax credit left it with a smaller loss for the fourth quarter. The development stage company reported a net loss of $17.2 million, or 33 cents per share.

TOPICS:

Merck-Sanofi Deal Held Up by Regulators

March 2, 2011 5:26 am | News | Comments

Drugmaker Merck & Co. said its planned venture with French counterpart Sanofi-Aventis SA to unite their animal health businesses has been delayed as regulators continue anti-trust reviews.

TOPICS:

DNA Sequencing Kits

March 1, 2011 7:30 am | Product Releases | Comments

Bioo Scientific announced the launch of the NEXTflex DNA Sequencing Kits and NEXTflex DNA Barcodes, designed to provide flexibility and high-throughput capabilities in sequencing applications at a cost savings.

TOPICS:

UHPLC Injector

March 1, 2011 7:26 am | Product Releases | Comments

VICI Valco’s Cheminert C72 Ultra-high Pressure UHPLC Injector features a proprietary stator coating that permits pressures up to 15,000 or 20,000 psi. Many of the latest analytical techniques require systems that are capable of this much pressure.

TOPICS:

Albira PET Imaging System Added to NDIIF

March 1, 2011 7:15 am | News | Comments

The University of Notre Dame has added Caretream’s Albira system to its In Vivo Imaging Core, part of the Notre Dame Integrated Imaging Facility.

TOPICS:

Agilent Acquires Two Leading Life Science Companies

March 1, 2011 7:07 am | News | Comments

Agilent Technologies Inc. has acquired BIOCIUS Life Sciences, Inc., developer of the RapidFire high-throughput mass spectrometry drug-screening platform, and Lab901, a leading electrophoresis equipment and consumables company.

TOPICS:

Scientists Find Hope for Overcoming Parkinson's

March 1, 2011 6:59 am | News | Comments

Parkinson's disease sufferers lack a sufficient amount of a brain chemical called dopamine. Previous research has shown that a novel protein known as protein kinase-C kills essential dopamine-producing cells in the brain.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading